TrialWorld journal of urology2023

Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected.

Gregor Duwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.